Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shi, Yuhong
NCT06145893: A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease	Recruiting	3	162	RoW	Hemay005, Mufemilast, Phosphodiesterase 4 (PDE4) inhibitors, Placebo	Ganzhou Hemay Pharmaceutical Co., Ltd	Behçet's Disease	11/24	03/25
UplighTED, NCT06307626: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease.	Recruiting	3	108	Europe, Japan, US, RoW	Efgartigimod PH20 SC, Placebo PH20 SC	argenx	Thyroid Eye Disease	02/26	10/27